Clinical suspicion of sarcopenic obesity and probable sarcopenic obesity in Colombian women with a history of surgical menopause: a cross-sectional study

Abstract

Objectives: To identify the frequency of clinical suspicion of sarcopenic obesity (CSSO) and probable sarcopenic obesity (PSO) and to estimate the association between them and surgical menopause.Methods: A cross-sectional study carried out in women residing in Colombia, ages 60 to 75 years. Body mass index, the SARC-F scale, SARC-CalF < 31, and SARC-CalF <33 versions adding the calf circumference measurement in the last two were used to identify CSSO. Muscle strength measurement was added to the above measures to establish PSO. Surgical menopause was defined in women who underwent bilateral oophorectomy simultaneously with hysterectomy before natural menopause. Adjusted and unadjusted logistic regression were performed between CSSO or PSO with surgical menopause, bilateral oophorectomy after natural menopause, and abdominal hysterectomy with ovarian preservation. All participants provided informed consent. P < 0.05 was statistically significant.Results: Seven hundred women 67.0 AE 4.8 years old were included; 23.7% were obese, 68.1% had reduced muscle strength, and 4.2% had surgical menopause. CSSO was found in 3.0% with SARC-F and with SARC-CalF < 31; whereas 2.0% were found with SARC-CalF <33. PSO was found in 2.4%, 1.5%, and 2.2% with SARC-F, SARC-CalF <31, and SARC-CalF <33, respectively. Surgical menopause was associated with PSO but was not associated with CSSO. Bilateral oophorectomy after menopause and hysterectomy with ovarian preservation were not associated with CSSO or PSO.Conclusions: In a group of older adult women, the frequency of CSSO was up to 3.0% and PSO up to 2.4%. Surgical menopause was statistically significantly associated with PSO. On the contrary, CSSO was not associated.

Sarcopenic obesity: a double whammy

“…This is an excellent segue into the topic of the study in the current issue 1 . The same review of PubMed showed the first mention of sarcopenic obesity in 1996 with 1,026 citations through January, 2022.…”

“…As the authors point out 1 individuals being over 60 years of age, sedentary lifestyle, high-fat diet, high alcohol consumption, and smoking all increase the likelihood of developing sarco-penic obesity. They also astutely point out sarcopenic obesity is associated with several comorbidities including increased insulin resistance, diabetes, cardiovascular disease, metabolic syndrome, dyslipidemia, arterial hypertension, stress, suicidal ideation, knee osteoarthritis, reduced coordination, or aerobic capacity, osteoporosis, fractures, and even all-cause mortality 17 …”

“…This is an excellent segue into the topic of the study in the current issue. 1 The same review of PubMed showed the first mention of sarcopenic obesity in 1996 with 1,026 citations through January, 2022. It is a multifactorial, progressive, and silent condition in which decreased skeletal muscle mass and function coexist with excessive body fat accumulation.…”

“…This issue of the journal includes an article by Mon-terrosa-Castro et al, 1 entitled “Clinical suspicion of sarcopenic obesity and probable sarcopenic obesity in Colombian women with a history of surgical menopause: A crosssectional study.” In these Colombian women, the authors, simply put, found an association between clinical suspicion of sarcopenic obesity and probable sarcopenic obesity depending on surgical management of the ovaries and menopausal status at the time of hysterectomy. If bilateral oophorectomy was done prior to menopause, there was an association with sarcopenic obesity, whereas, if performed after menopause, there was not.…”

Clinical considerations for sarcopenia in older Colombian Afro-descendant and mestizo women

“…Although several cut-off points are indicated for assessing muscle strength, <16.0 kg was used, as suggested in the EWGSOP2 criteria. 12,13,29,30 Two measurements were established for PS:…”